We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIBB
2326
DELISTED
Hibbett, Inc. Common Stock
HIBB
$258K ﹤0.01%
6,566
+5,070
+339% +$147K
CLFD icon
2327
Clearfield
CLFD
$390M
$257K ﹤0.01%
12,731
+10,022
+370% +$179K
NC icon
2328
NACCO Industries
NC
$316M
$257K ﹤0.01%
14,112
+8,422
+148% +$183K
NWPX icon
2329
NWPX Infrastructure Inc
NWPX
$1.11B
$257K ﹤0.01%
9,705
+6,914
+248% +$183K
TEVA icon
2330
Teva Pharmaceuticals
TEVA
$42.6B
$257K ﹤0.01%
28,530
+27,641
+3,109% +$292K
TAST
2331
DELISTED
Carrols Restaurant Group, Inc.
TAST
$257K ﹤0.01%
39,791
+31,969
+409% +$198K
EMWP
2332
DELISTED
Eros Media World PLC
EMWP
$257K ﹤0.01%
5,820
+4,566
+364% +$266K
RLGT icon
2333
Radiant Logistics
RLGT
$406M
$256K ﹤0.01%
49,964
+35,085
+236% +$169K
SGC icon
2334
Superior Group of Companies
SGC
$210M
$256K ﹤0.01%
11,038
+8,770
+387% +$171K
CTMX icon
2335
CytomX Therapeutics
CTMX
$730M
$255K ﹤0.01%
38,414
+22,656
+144% +$168K
WTBA icon
2336
West Bancorporation
WTBA
$511M
$255K ﹤0.01%
16,126
+13,221
+455% +$224K
SYRE icon
2337
Spyre Therapeutics
SYRE
$8.98B
$254K ﹤0.01%
1,431
+1,007
+238% +$186K
FISI icon
2338
Financial Institutions
FISI
$825M
$253K ﹤0.01%
16,443
+13,774
+516% +$226K
FSTA icon
2339
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.43B
$253K ﹤0.01%
6,624
-6,128
-48% -$230K
PLTR icon
2340
Palantir
PLTR
$430B
$253K ﹤0.01%
+26,608
New +$253K
LUMN icon
2341
Lumen
LUMN
$6.6B
$252K ﹤0.01%
24,999
-21,319
-46% -$222K
SNDX icon
2342
Syndax Pharmaceuticals
SNDX
$1.7B
$252K ﹤0.01%
17,044
+13,064
+328% +$199K
CALA
2343
DELISTED
Calithera Biosciences, Inc
CALA
$252K ﹤0.01%
3,654
+3,027
+483% +$264K
ACBI
2344
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$252K ﹤0.01%
22,229
+18,415
+483% +$205K
CBMG
2345
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$252K ﹤0.01%
13,739
+10,889
+382% +$183K
HR
2346
DELISTED
Healthcare Realty Trust Incorporated
HR
$252K ﹤0.01%
8,365
-20,349
-71% -$586K
CNP icon
2347
CenterPoint Energy
CNP
$26.7B
$251K ﹤0.01%
12,956
+1,296
+11% +$25.4K
CTO
2348
CTO Realty Growth
CTO
$823M
$251K ﹤0.01%
20,991
+14,411
+219% +$161K
DQ
2349
Daqo New Energy
DQ
$1.01B
$251K ﹤0.01%
+9,265
New +$206K
RVTY icon
2350
Revvity
RVTY
$13.1B
$251K ﹤0.01%
2,003
+534
+36% +$61.4K
92 93
94
95 96

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.